PHI with Silicosis

Read in German: PKV mit Kiesellunge

How does this condition affect your private health insurance?

Kiesellunge, medically known as Silicosis, is an irreversible occupational lung disease caused by the inhalation of crystalline silica dust. Primarily affecting workers in mining, construction, and foundry industries, it leads to progressive inflammation and scarring (fibrosis) of the lungs. Symptoms like shortness of breath, persistent cough, and fatigue often develop years after exposure, gradually worsening. Silicosis impairs lung function, increasing susceptibility to infections, particularly tuberculosis, and other severe respiratory complications, including lung cancer. There is no cure, and treatment focuses on managing symptoms, preventing further exposure, and addressing complications.

PKV Risk Assessment

Very High Risk of Rejection

Individual, specialized PHI providers may still insure you, but with a significant surcharge.

Impact on Your Insurance Policy

Duration of Illness (Initial)

Symptoms typically appear gradually over several years to decades after initial exposure.

Duration of Illness (Lifetime)

Chronic, progressive, and lifelong once symptoms manifest.

Cost of Treatment (Initial)

Moderate to high (initial diagnosis, imaging, pulmonary function tests, and symptom management).

Cost of Treatment (Lifetime)

Very high (ongoing respiratory support, medications, management of complications like infections, potential lung transplant in severe cases).

Mortality Rate

High, particularly with progressive massive fibrosis, acute silicosis, or severe complications like respiratory failure, cor pulmonale, or tuberculosis.

Risk of Secondary Damages

Very high (respiratory failure, pulmonary hypertension, cor pulmonale, increased susceptibility to tuberculosis, chronic bronchitis, lung cancer).

Probability of Full Recovery

Extremely low, as the lung damage (fibrosis) is irreversible and progressive.

Underlying Disease Risk

High probability of developing Tuberculosis, chronic obstructive pulmonary disease (COPD), lung cancer, and rheumatoid arthritis in predisposed individuals.

The information provided is for general informational purposes only and is not a substitute for professional medical or insurance advice. Always consult with a qualified professional for any health concerns or before making any insurance decisions.